trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
-
Chinese vaccines help developing countries cope with tough COVID-19 situation: US media
NEW YORK -- Chinese vaccines have helped some developing countries in Asia push forward their vaccination drives, the Wall Street Journal reported earlier this week.
2021-06-21 -
China to promote use of TCM in prevention, treatment of infectious disease outbreaks
BEIJING -- Chinese health authorities have issued a guideline to give full play to the role of traditional Chinese medicine (TCM) in the prevention and treatment of new outbreaks of infectious diseases.
2021-06-17 -
Study shows generic drugs match name-brand counterparts
A recent study led by the National Healthcare Security Administration shows 14 generic drugs included in the national drug bulk-buy program are as safe and effective as their name-brand counterparts, the administration said on Wednesday.
2021-06-11 -
Chinese experts set up model to predict stroke risk
A group of Chinese cardiovascular experts recently established the first polygenic risk score (PRS) model to evaluate risk of stroke in the Chinese population, and provide a practical assessment tool for early screening and prevention.
2021-06-03 -
Chinese inactivated vaccines effective against COVID-19 in phase-3 human trials: study
Two inactivated vaccines developed by Sinopharm have shown to be safe and effective against COVID-19 in phase-3 human trials, according to a study published this week in The Journal of the American Medical Association.
2021-05-28 -
Hong Kong-led study discovers simeprevir as potent treatment for COVID-19
A Hong Kong-led global study showed that a hepatitis C virus drug simeprevir can strongly suppress the replication of SARS-CoV-2, the virus that causes COVID-19.
2021-05-11 -
Chinese scientists discover gene associated with epilepsy
Chinese scientists have recently discovered a gene responsible for epilepsy, a neurological disorder of the brain.
2021-05-10 -
Online sales of prescription drugs 'will expand patient choices'
China's decision to greenlight the online sales of prescription drugs will give patients more options and make it easier for the public to access healthcare services, experts said.
2021-04-28 -
Nanobowls in Medicine
This article will discuss the use of one of these structures, nanobowls, in the field of medicine.
2021-04-25 -
Colon cancer screening key to survival
Boosting public awareness of and compliance with regular colorectal cancer screening will play a vital role in increasing the disease's overall survival rates in China, oncology experts have said.
2021-04-19